THE UNIVERSITY OF BRITISH COLUMBIA
The Respiratory Evaluation Sciences Program (RESP) is a comprehensive epidemiology, health outcomes, and health economics program focused on chronic respiratory diseases (namely asthma and chronic obstructive pulmonary disease [COPD]).
We are hosted within Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, UBC. Our group has diverse expertise in using clinical data, real-world 'big' data, and computer simulations (disease modeling) techniques to evaluate the real-world effectiveness of health technologies and their 'value for money' potential. Our research has continuously been supported through multiple grants from CIHR and other agencies.
See more of our research by following categories:
Background: Asthma is a common chronic respiratory disease with a rapidly changing burden. We aimed to investigate 20-year trends in asthma-related hospitalisations in Canada. Methods: Using the Canadian comprehensive nationwide hospitalisation data (199...
Acute COPD Exacerbation Prediction Tool (ACCEPT)
A parametric model to jointly characterize rate, duration, and severity of exacerbations in episodic diseases
RESP is hosted within Collaboration for Outcomes Research and Evaluation within UBC Faculty of Pharmaceutical Sciences. Our partners include UBC Division of Respiratory Medicine, and Centre for Clinical Epidemiology and Evaluation.
Our research has been funded by peer-reviewed grants from multiple institutions, including: